Related Post
AI Will Not Close the Readiness Gap in Clinical Trials. It Will Expose It.
The risk in an AI-first trial is not that teams use the tools. It is…
Joel Selzer
The Earliest Warning Sign: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
Most protocol deviations start as human problems, not operational ones, but risk-based monitoring typically relies…
Brian S McGowan, PhD
Fresh Starts, Real Readiness: Turning Site Initiation into a Trial Success Multiplier
By leveraging the Fresh Start Effect at site initiation and shifting from passive training to…
